ATE218060T1 - Zusammenstellungen die beta-amyloid protein bedingte zytotoxizität verhindern - Google Patents

Zusammenstellungen die beta-amyloid protein bedingte zytotoxizität verhindern

Info

Publication number
ATE218060T1
ATE218060T1 AT97930746T AT97930746T ATE218060T1 AT E218060 T1 ATE218060 T1 AT E218060T1 AT 97930746 T AT97930746 T AT 97930746T AT 97930746 T AT97930746 T AT 97930746T AT E218060 T1 ATE218060 T1 AT E218060T1
Authority
AT
Austria
Prior art keywords
amyloid protein
compositions
optionally substituted
protein related
prevent beta
Prior art date
Application number
AT97930746T
Other languages
English (en)
Inventor
Masaomi Miyamoto
Keisuke Hirai
Giichi Goto
Original Assignee
Takeda Chemical Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Takeda Chemical Industries Ltd filed Critical Takeda Chemical Industries Ltd
Application granted granted Critical
Publication of ATE218060T1 publication Critical patent/ATE218060T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/047—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates having two or more hydroxy groups, e.g. sorbitol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/12—Ketones
    • A61K31/122—Ketones having the oxygen directly attached to a ring, e.g. quinones, vitamin K1, anthralin

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT97930746T 1996-07-11 1997-07-10 Zusammenstellungen die beta-amyloid protein bedingte zytotoxizität verhindern ATE218060T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP18209596 1996-07-11
PCT/JP1997/002391 WO1998002149A2 (en) 1996-07-11 1997-07-10 Use of idebenone and analogues against beta amyloid induced cytotoxicity

Publications (1)

Publication Number Publication Date
ATE218060T1 true ATE218060T1 (de) 2002-06-15

Family

ID=16112269

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97930746T ATE218060T1 (de) 1996-07-11 1997-07-10 Zusammenstellungen die beta-amyloid protein bedingte zytotoxizität verhindern

Country Status (7)

Country Link
US (1) US6271266B1 (de)
EP (1) EP0915696B1 (de)
AT (1) ATE218060T1 (de)
AU (1) AU3458997A (de)
CA (1) CA2252519A1 (de)
DE (1) DE69712888D1 (de)
WO (1) WO1998002149A2 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2610152C (en) * 2005-06-01 2018-04-10 Edison Pharmaceuticals, Inc. Redox-active therapeutics for treatment of mitochondrial diseases and other conditions and modulation of energy biomarkers
ES2823728T3 (es) * 2005-09-15 2021-05-10 Ptc Therapeutics Inc Variantes de cola de agentes terapéuticos con actividad redox para el tratamiento de enfermedades mitocondriales y otras afecciones y la modulación de biomarcadores de energía
EA019675B1 (ru) 2006-02-22 2014-05-30 Эдисон Фармасьютикалз, Инк. Редокс-активные терапевтические средства для лечения митохондриальных заболеваний и модуляции биомаркера коэнзима q
EP1891946A1 (de) * 2006-08-14 2008-02-27 Santhera Pharmaceuticals (Schweiz) AG Transmukosale Verabreichung von 2,3-dimethoxy-5-methyl-6-(10-hydroxydecyl)-1,4-benzoquinon
EP3018122B1 (de) 2007-11-06 2018-10-10 BioElectron Technology Corporation 4-(p-quinonyl)-2-hydroxybutanamid-derivate zur behandlung von mitochondrialen erkrankungen
BRPI0918139B1 (pt) 2008-09-10 2024-04-30 Ptc Therapeutics, Inc Composição, alimento medicinal ou funcional, suplemento alimentar ou dietético para tratamento de distúrbios de desenvolvimento pervasivos com terapêuticos redox-ativos
US8263094B2 (en) * 2008-09-23 2012-09-11 Eastman Chemical Company Esters of 4,5-disubstituted-oxy-2-methyl-3,6-dioxo-cyclohexa-1,4-dienyl alkyl acids and preparation thereof
RS55173B1 (sr) * 2010-08-16 2017-01-31 Santhera Pharmaceuticals (Schweiz) Ag Uređaj i sistem za proizvodnju aerosola sa poboljšanim protokom vazduha
WO2014035356A1 (en) * 2012-08-31 2014-03-06 Mahmut Bilgic Tablet formulations comprising a quinone derivative active agent
WO2016100579A1 (en) 2014-12-16 2016-06-23 Edison Pharmaceuticals, Inc., Polymorphic and amorphous forms of (r)-2-hydroxy-2-methyl-4-(2,4,5-trimethyl-3,6-dioxocyclohexa-1,4-dienyl)butanamide
CN113024369A (zh) 2015-12-17 2021-06-25 Ptc医疗公司 用于治疗氧化应急障碍的化合物
KR102742339B1 (ko) 2017-04-21 2024-12-13 유니버시티 오브 타스마니아 치료 화합물 및 방법
JP7586815B2 (ja) 2018-10-17 2024-11-19 ピーティーシー セラピューティクス， インコーポレイテッド α－シヌクレイノパチー、タウオパチー、および他の障害を抑制および処置するための２，３，５－トリメチル－６－ノニルシクロヘキサ－２，５－ジエン－１，４－ジオン
CN118175991A (zh) 2021-07-08 2024-06-11 Ptc医疗公司 包含2,3,5-三甲基-6-壬基环己-2,5-二烯-1,4-二酮的药物组合物
CN119792259A (zh) * 2024-10-14 2025-04-11 中国农业大学 艾地苯醌在制备朊病毒病药物中的应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH08768B2 (ja) 1989-08-24 1996-01-10 武田薬品工業株式会社 神経成長因子分泌誘導剤
JP2849286B2 (ja) * 1992-07-09 1999-01-20 三菱電機株式会社 半導体装置の製造方法
EP0629400B1 (de) * 1993-06-18 1999-09-22 Takeda Chemical Industries, Ltd. Idebenone-haltige Zusammensetzungen zur Behandlung von M. Alzheimer

Also Published As

Publication number Publication date
US6271266B1 (en) 2001-08-07
EP0915696B1 (de) 2002-05-29
DE69712888D1 (de) 2002-07-04
WO1998002149A2 (en) 1998-01-22
EP0915696A2 (de) 1999-05-19
WO1998002149A3 (en) 1998-06-04
CA2252519A1 (en) 1998-01-22
AU3458997A (en) 1998-02-09

Similar Documents

Publication Publication Date Title
ES2134847T3 (es) Derivados de taxol.
PT1109812E (pt) Pirrolobenzodiazepinas
DE69712888D1 (de) ZUSAMMENSTELLUNGEN DIE beta-AMYLOID PROTEIN BEDINGTE ZYTOTOXIZITÄT VERHINDERN
TW328535B (en) Functional photoinitiators and their manufacture
EP0513387A4 (en) Active oxygen inhibitor
AU1497997A (en) Use of estrogen antagonists and estrogen agonists in inhibiting pathological conditions
EA199900373A2 (ru) Фармацевтические композиции
BR9605309A (pt) Composições de derivados piperazina
ES2176402T3 (es) Compuestos sulfatos de 2,2-difluoro-3-carbomoil-ribosa y procedimientopara la preparacion de beta-nucleosidos.
FI963169A0 (fi) Enkefalinaasin ja ACE:n inhibittoreina käyttökelpoisia uusia merkaptoasetyyliamido-1,3,4,5-tetrahydrobents/c/-atsepin-3-onidisulfidijohdannaisia
BG103310A (en) Benzonaphthyridins as bronchial therapeutical means
PT918776E (pt) Sintese total de acilfulvenos antitumorais
ES2012646A6 (es) Un procedimiento para la preparacion de derivados de piridazinona.
AU7915491A (en) Phenyl mercaptotetrazole/tolyltriazole corrosion inhibiting compositions
EP1042352A4 (de) Androgene steroidderivate und ein verfahren zur herstellung und verwendung derselben
ES2122258T3 (es) 4-azaesteroides 15 sustituidos.
DK1042319T3 (da) Dihydrobenzofuraner
ATE308548T1 (de) Glycerophosphoinositol-derivate als cytosolic a2 phospholipase modulatoren
ES2093091T3 (es) Derivado de glutation.
NZ326675A (en) Oxazoline arthropodicides
DE69936052D1 (de) N1 modifizierte glycopeptide
HRP20010885B1 (en) Ethanesulfonyl-piperidine derivatives
BG105249A (en) Fkbp inhibitors
ZA9811380B (de)
ES2122751T3 (es) Composicion antialergica que comprende un compuesto diester fosforico.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties